Good laboratory practices (GLP) are critical to ensure the reliability and integrity of data produced across different pharmaceutical and related industries. Conforming to GLP standards not only translates to regulatory compliance but is crucial to maintaining the quality, safety, and reputation of the product. However, despite the significance of GLP compliance, several companies face difficulties when implementing these GLP standards.
The current article discusses five common GLP testing mistakes and offers insights on how to avoid them
-
Lack of comprehensive GLP testing training initiatives
One of the most critical elements of successful GLP compliance is ensuring all individuals involved in the laboratory receive complete training on GLP compliance and principles. Inadequate or minimal GLP testing training is a common mistake. This mistake leads to errors, misunderstanding, and non-compliance. Hence, companies and drug developers should have robust programs for the laboratory staff. These training programs should include different aspects of GLP testing, such as quality control measures, sample handling, equipment calibration, and documentation practices. Importantly, comprehensive training is critical for advanced and complex technology such as LC-MS mass spectrometry.
-
Insufficient documentation
Detailed and accurate documentation demonstrates GLP compliance and ensures data reproducibility and predictability. However, companies struggle to develop accurate and complete documents, leading to improper data storage, missing signatures, or incomplete records. Besides, failure to maintain complete documentation not only goes against regulatory compliance but also reduces the credibility of generated results. Hence, companies should have standardized protocols for documenting all laboratory activities, such as test results, observation, experimental protocols, and deviation from standard methods.
-
Inadequate quality control measures
Efficient quality control measures can identify and prevent discrepancies and errors in laboratory protocols and operations. However, some companies underscore the significance of quality control procedures, which leads to regulatory non-compliance and compromised data quality. Common mistakes include not performing proficiency testing, lack of consistent maintenance, and inadequate instrument calibration. Hence, companies should have robust quality control procedures encompassing different elements of laboratory operations, including data analysis, sample preparation, and documentation.
Must Read: The Role of Assay Testing in Clinical Diagnostics
-
Inability to address safety and environmental issues
Laboratories are dynamic surroundings and pose inherent risk factors associated with physical, biological, and chemical hazards. Neglecting safety and environmental considerations can compromise the well-being of laboratory staff and the integrity of generated data. Some common reasons include lack of PPE gear, inadequate waste management, and improper storage of hazardous chemicals. Companies should have a culture of environmental and safety understanding and prioritize regular safety inspection training of laboratory staff and approved SOPs to minimize risk factors.
-
Failing to stay updated with regulatory guidelines
Regulatory requirements around GLP compliance are constantly updated. This ever-evolving landscape requires ongoing adaptability and vigilance by companies and organizations. Failing to stay updated with regulatory transformations results in non-compliance with regulatory standards and potentially causes legal consequences. Some common mistakes leading to non-compliance with regulatory policies include failing to add new modifications to existing protocols, outdated guidelines, and missing recent regulatory updates. Companies can avoid these pitfalls by establishing systems to monitor regulatory changes, such as participating in conferences, engaging with regulatory decision-makers, and subscribing to relevant newsletters. Periodic review of procedures and policies can help companies remain up-to-date with regulatory guidelines and best practices.
